Community-Informed Development of a Campaign to Increase HIV Pre-exposure Prophylaxis (PrEP) Awareness Among African-Ame

  • PDF / 540,096 Bytes
  • 11 Pages / 595.276 x 790.866 pts Page_size
  • 99 Downloads / 195 Views

DOWNLOAD

REPORT


Community-Informed Development of a Campaign to Increase HIV Pre-exposure Prophylaxis (PrEP) Awareness Among African-American Young Adults Jelani Kerr 1 & Suur Ayangeakaa 1 & Ryan Combs 1 & Lesley Harris 2 & Jeanelle Sears 3 & Toya Northington 4 & Kelsey Burton 1 & Emma Sterrett-Hong 2 & Kimberly Parker 5 & Karen Krigger 6 Received: 12 May 2020 / Revised: 6 August 2020 / Accepted: 10 August 2020 # W. Montague Cobb-NMA Health Institute 2020

Abstract Pre-exposure prophylaxis (PrEP) for HIV prevention can help reduce racial/ethnic HIV disparities in the USA. However, the benefits of PrEP have not been equally distributed across races. Community-informed, culturally tailored media has the potential to increase PrEP awareness and acceptability among vulnerable African-American populations. More research is needed to identify media preferences around PrEP for these groups in order to optimize effectiveness of health messaging. This study details the development of a community-informed multimedia (print, digital, Internet radio, website, social media) campaign to increase PrEP awareness among African-American young adults (age 18–29 years). Eleven focus groups with African-American young adults and a community advisory board informed the intervention. Focus group participants expressed concerns with PrEP safety, efficacy, accessibility, the universality of HIV vulnerability, and representation. Campaign elements were then developed based on this feedback. Future studies should examine the effectiveness of culturally tailored multimedia PrEP campaigns. Keywords Pre-exposure prophylaxis . PrEP . HIV . African-American . Media . Community

Introduction Disproportionately, high HIV rates among African-American young people are a pressing public health concern. AfricanAmericans account for more than 40% of HIV cases in the USA, despite accounting for 13% of the population [1, 2]. Half of African-American men who have sex with men (MSM) will be diagnosed with HIV in their lifetime [1]. Similarly, 58% of new HIV diagnoses among women are * Jelani Kerr [email protected] 1

Health Promotion and Behavioral Sciences, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, USA

2

Kent School of Social Work, University of Louisville, Louisville, KY, USA

3

Department of Human Services, Bowling Green State University, Bowling Green, OH, USA

4

Speed Art Museum, University of Louisville, Louisville, KY, USA

5

Parker Owens Research Group, Dallas, TX, USA

6

School of Medicine, University of Louisville, Louisville, KY, USA

among African-Americans [3]. African-Americans comprise 50% of new HIV cases among persons aged 20–24 [4]. Clearly, intervention is needed. Biomedical innovations demonstrate promise in reducing HIV disparities. Among these is pre-exposure prophylaxis (PrEP), a medication regimen to reduce HIV infection risk among HIV-negative people. Truvada and Descovy are two antiretroviral medications developed as treatment for people living with HIV. They were approved for PrEP use in